Product NDC: | 49527-736 |
Proprietary Name: | CLINIQUE |
Non Proprietary Name: | octisalate, homosalate, oxybenzone, avobenzone, octocrylene |
Active Ingredient(s): | 3; 5; 5; 2.7; 4 mL/100mL; mL/100mL; mL/100mL; mL/100mL; mL/100mL & nbsp; octisalate, homosalate, oxybenzone, avobenzone, octocrylene |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49527-736 |
Labeler Name: | CLINIQUE LABS INC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20100601 |
Package NDC: | 49527-736-01 |
Package Description: | 1 TUBE in 1 CARTON (49527-736-01) > 150 mL in 1 TUBE (49527-736-02) |
NDC Code | 49527-736-01 |
Proprietary Name | CLINIQUE |
Package Description | 1 TUBE in 1 CARTON (49527-736-01) > 150 mL in 1 TUBE (49527-736-02) |
Product NDC | 49527-736 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | octisalate, homosalate, oxybenzone, avobenzone, octocrylene |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100601 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | CLINIQUE LABS INC |
Substance Name | AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE |
Strength Number | 3; 5; 5; 2.7; 4 |
Strength Unit | mL/100mL; mL/100mL; mL/100mL; mL/100mL; mL/100mL |
Pharmaceutical Classes |